Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00101205
Status:
TERMINATED
Last Update Posted:
2014-02-24
First Post:
2005-01-07
Brief Title:
Oxaliplatin Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Childhood Solid Tumor Protocol Specific |
| Angioimmunoblastic T-cell Lymphoma |
| B-cell Childhood Acute Lymphoblastic Leukemia |
| B-cell Chronic Lymphocytic Leukemia |
| Childhood Burkitt Lymphoma |
| Childhood Diffuse Large Cell Lymphoma |
| Childhood Grade III Lymphomatoid Granulomatosis |
| Childhood Immunoblastic Large Cell Lymphoma |
| Childhood Nasal Type Extranodal NKT-cell Lymphoma |
| Hepatosplenic T-cell Lymphoma |
| Intraocular Lymphoma |
| Noncutaneous Extranodal Lymphoma |
| Peripheral T-cell Lymphoma |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Anaplastic Large Cell Lymphoma |
| Recurrent Childhood Grade III Lymphomatoid Granulomatosis |
| Recurrent Childhood Large Cell Lymphoma |
| Recurrent Childhood Lymphoblastic Lymphoma |
| Recurrent Childhood Small Noncleaved Cell Lymphoma |
| Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma |
| Recurrent Mycosis FungoidesSezary Syndrome |
| RecurrentRefractory Childhood Hodgkin Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Refractory Hairy Cell Leukemia |
| Small Intestine Lymphoma |
| T-cell Childhood Acute Lymphoblastic Leukemia |
| T-cell Large Granular Lymphocyte Leukemia |
Keywords: